Literature DB >> 23677461

Capsule commentary on Efird et al., identifying the risks of anticoagulation in patients with substance abuse.

Katherine Kirley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23677461      PMCID： PMC3785659          DOI： 10.1007/s11606-013-2486-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.

Authors:  T J Bungard; W A Ghali; F A McAlister; A M Buchan; A J Cave; P G Hamilton; L B Mitchell; A Shuaib; K K Teo; R T Tsuyuki
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

2.  Scores to predict major bleeding risk during oral anticoagulation therapy: a prospective validation study.

Authors:  Jacques Donzé; Nicolas Rodondi; Gérard Waeber; Pierre Monney; Jacques Cornuz; Drahomir Aujesky
Journal:  Am J Med       Date:  2012-08-30       Impact factor: 4.965

3.  Identifying the risks of anticoagulation in patients with substance abuse.

Authors:  Lydia M Efird; Donald R Miller; Arlene S Ash; Dan R Berlowitz; Al Ozonoff; Shibei Zhao; Joel I Reisman; Guneet K Jasuja; Adam J Rose
Journal:  J Gen Intern Med       Date:  2013-04-26       Impact factor: 5.128

4.  National trends in oral anticoagulant use in the United States, 2007 to 2011.

Authors:  Kate Kirley; Dima M Qato; Rachel Kornfield; Randall S Stafford; G Caleb Alexander
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.